Page last updated: 2024-12-04

sym-homospermidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sym-homospermidine: analog of spermidine isolated from sandal leaves (Santalum album L.); structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

sym-homospermidine : A polyazaalkane comprising undecane with three aza groups placed at the 1-, 6- and 11-positions. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID368
CHEMBL ID36119
CHEBI ID16554
SCHEMBL ID138047
MeSH IDM0051454

Synonyms (30)

Synonym
bdbm50032505
CHEBI:16554 ,
n-(4-aminobutyl)butane-1,4-diamine
n-(4-aminobutyl)-1,4-butanediamine
C06366
bis(4-aminobutyl)amine
homospermidine
1,6,11-triazaundecane
sym-homospermidine
n1-(4-aminobutyl)butane-1,4-diamine
4427-76-3
CHEMBL36119 ,
1,4-butanediamine, n-(4-aminobutyl)-
n'-(4-aminobutyl)butane-1,4-diamine
0ij25x1h4r ,
unii-0ij25x1h4r
AKOS015855215
sym-homospermidine-d4 trihydrochloride
n-(4-aminobutyl)-1,4-diaminobutane
dibutylamine, 4,4'-diamino-
4,4'-iminobis(butylamine)
1,4-butanediamine, n1-(4-aminobutyl)-
SCHEMBL138047
4,4'-diaminodibutylamine
DTXSID00196098
1,9-diamino-5-azanonane
n-(4-aminobutyl)-1,4-butanediamine, 9ci
FT-0669237
Q3882311
EN300-7434636

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
triamineAny polyamine that contained three amino groups.
polyazaalkaneAny azaalkane in which two or more carbons in the chain are replaced by nitrogen.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Deoxyhypusine synthaseRattus norvegicus (Norway rat)IC50 (µMol)556.00000.03001.76503.5000AID56588
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (15)

Assay IDTitleYearJournalArticle
AID96668Percentage of spermine (after 48 hr exposure to 100 uM) in L1210 cells.1997Journal of medicinal chemistry, May-09, Volume: 40, Issue:10
A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics.
AID98715Growth inhibitory activity against L1210 cells (48h)1997Journal of medicinal chemistry, May-09, Volume: 40, Issue:10
A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics.
AID56588In vitro IC50 value by measuring the inhibition of deoxyhypusine synthase.1995Journal of medicinal chemistry, Aug-04, Volume: 38, Issue:16
Diamine and triamine analogs and derivatives as inhibitors of deoxyhypusine synthase: synthesis and biological activity.
AID96530Percentage of spermine (after 48 hr exposure to 500 uM) in L1210 cells.1997Journal of medicinal chemistry, May-09, Volume: 40, Issue:10
A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics.
AID44879Growth inhibition was measured against CHO cell line; - indicates >100 uM1995Journal of medicinal chemistry, Aug-04, Volume: 38, Issue:16
Diamine and triamine analogs and derivatives as inhibitors of deoxyhypusine synthase: synthesis and biological activity.
AID160318Binding affinity values for polyamine transporter was determined1997Journal of medicinal chemistry, May-09, Volume: 40, Issue:10
A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics.
AID97152Effect on Spermidine/Spermine-Acetyltransferase (SSAT ) at 10 uM at 48 hour in L1210 cells1997Journal of medicinal chemistry, May-09, Volume: 40, Issue:10
A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics.
AID97537Effect on S-Adenosyl-methionine decarboxylase (AdoMetDC) tested at 1 uM at 6 hour in L1210 cells1997Journal of medicinal chemistry, May-09, Volume: 40, Issue:10
A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics.
AID160317Binding affinity to the mouse polyamine transporter on the L1210 cell surface2003Journal of medicinal chemistry, Jun-19, Volume: 46, Issue:13
Molecular requirements for targeting the polyamine transport system. Synthesis and biological evaluation of polyamine-anthracene conjugates.
AID96681Percentage of spermine (after 48 hr exposure to 500 uM) in L1210 cells.1997Journal of medicinal chemistry, May-09, Volume: 40, Issue:10
A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics.
AID96497Percentage of putrescine (after 48 hr exposure to 100 uM) in L1210 cells.1997Journal of medicinal chemistry, May-09, Volume: 40, Issue:10
A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics.
AID98950Effect on ornithine decarboxylase (ODC) tested at 1 uM at 4 hour in L1210 cells1997Journal of medicinal chemistry, May-09, Volume: 40, Issue:10
A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics.
AID96517Percentage of spermine (after 48 hr exposure to 100 uM) in L1210 cells.1997Journal of medicinal chemistry, May-09, Volume: 40, Issue:10
A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics.
AID98716Growth inhibitory activity against L1210 cells (96h)1997Journal of medicinal chemistry, May-09, Volume: 40, Issue:10
A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics.
AID210118Inhibition of spermidine transport determined in T-47D human breast cancer cells2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
Xylylated dimers of putrescine and polyamines: influence of the polyamine backbone on spermidine transport inhibition.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (105)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (10.48)18.7374
1990's2 (1.90)18.2507
2000's3 (2.86)29.6817
2010's88 (83.81)24.3611
2020's1 (0.95)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.49 (24.57)
Research Supply Index4.67 (2.92)
Research Growth Index6.16 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other106 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]